Associated Press
NEWARK, N.J. (AP) — Ziggy Reid tallied 18 points and 10 rebounds to lift Merrimack to a 61-54 win over NJIT on Thursday night.
Reid hit 4 of 6 3-pointers. Mikey Watkins had 11 points for Merrimack (2-0).
Miles Coleman had 19 points for the Highlanders (0-1) in their season opener. Antwuan Butler added 11 points. Dylan O’Hearn had 10 points and six rebounds.
___
For more AP college basketball coverage: https://apnews.com/hub/college-basketball and http://twitter.com/AP_Top25
___
This was generated by Automated Insights, http://www.automatedinsights.com/ap, using data from STATS LLC, https://www.stats.com
share
recommended
Last Night in College Basketball: Iowa State, Iowa Played a Wild Back-And-Forth
Top 25 college athletes with highest NIL valuations
4 Takeaways From No. 5 UConn's 71-63 Win Over Texas
2025-26 Men's March Madness Odds: Michigan Becomes New Favorite
Purdue HC Matt Painter on Losing No. 1 Ranking: 'It Really Isn't That Important'
115-Year-Old Boston Arena Where Babe Ruth Played Hockey — Yes, Hockey — Closing
Last Night in College Basketball: No. 10 Iowa State Passes Test vs. No. 11 Iowa
College Basketball Top 10, Bubble Team NET Rankings: Michigan, UConn are No. 1
Top 10 men's college basketball players with highest NIL valuations
Item 1 of 3
recommended
Last Night in College Basketball: Iowa State, Iowa Played a Wild Back-And-Forth
Top 25 college athletes with highest NIL valuations
4 Takeaways From No. 5 UConn's 71-63 Win Over Texas
2025-26 Men's March Madness Odds: Michigan Becomes New Favorite
Purdue HC Matt Painter on Losing No. 1 Ranking: 'It Really Isn't That Important'
115-Year-Old Boston Arena Where Babe Ruth Played Hockey — Yes, Hockey — Closing
Last Night in College Basketball: No. 10 Iowa State Passes Test vs. No. 11 Iowa
College Basketball Top 10, Bubble Team NET Rankings: Michigan, UConn are No. 1
Top 10 men's college basketball players with highest NIL valuations
Item 1 of 3
FOX SPORTS™, SPEED™, SPEED.COM™ & © 2025 Fox Media LLC
and Fox Sports Interactive Media, LLC. All rights reserved. Use of this
website (including any and all parts and components) constitutes your
acceptance of these
Terms of Use and Privacy Policy | Advertising Choices | Your Privacy Choices | Closed Captioning
